- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
UPDATED May 29, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,602 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
VOW | kr6.10 | 5.0% | -44.4% | kr694.4m | kr11.00 | PB1.8x | E97.5% | 0% | Commercial Services | ||
ATAKP | ₺49.32 | 1.5% | n/a | ₺6.8b | ₺67.66 | PE23.1x | E72.8% | n/a | Food, Beverage & Tobacco | ||
GIG | kr30.45 | -0.8% | 16.0% | kr4.0b | kr45.03 | PE19x | E36.2% | n/a | Consumer Services | ||
AESI | US$23.30 | -1.8% | 49.2% | US$2.6b | US$26.82 | PE19.6x | E48.9% | 3.6% | Energy | ||
CALTX | kr203.20 | 78.2% | 121.1% | kr10.9b | kr208.00 | PS9x | E50.3% | n/a | Pharmaceuticals & Biotech | ||
ARES | US$142.17 | -1.8% | 63.2% | US$44.7b | US$152.17 | PE64.4x | E42.1% | 2.6% | Diversified Financials | ||
AXSM | US$75.21 | -2.1% | 1.9% | US$3.6b | US$123.56 | PS14.2x | E65.1% | n/a | Pharmaceuticals & Biotech | ||
GAU | CA$2.46 | 1.7% | 215.4% | CA$637.9m | CA$2.84 | PE35.5x | E41.1% | n/a | Materials | ||
TGTX | US$16.36 | -7.6% | -38.6% | US$2.4b | US$31.50 | PE56.8x | E48.0% | n/a | Pharmaceuticals & Biotech | ||
ADOC | €8.80 | -4.5% | 122.2% | €126.7m | €9.70 | PS20.9x | E104.5% | n/a | Pharmaceuticals & Biotech | ||
GWIND | ₺30.36 | 1.5% | 75.3% | ₺16.4b | ₺39.71 | PE26.3x | E60.9% | 1.5% | Utilities | ||
NVG | zł2.07 | -3.3% | 27.0% | zł72.5m | zł3.71 | PE23.6x | E33.8% | n/a | Diversified Financials | ||
MBTN | CHF0.011 | 3.7% | -98.1% | CHF263.4m | n/a | PS2x | E82.0% | n/a | Semiconductors | ||
NEWBRY | kr2.99 | -5.4% | -25.3% | kr72.5m | kr8.00 | PS3.2x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
KEBNI B | kr1.50 | -0.4% | 35.5% | kr407.8m | kr2.20 | PS4.4x | E90.4% | n/a | Tech | ||
MVW | kr8.10 | -0.6% | 28.2% | kr265.0m | kr12.00 | PS24.6x | E69.0% | n/a | Materials | ||
AGP | €8.10 | -2.1% | 151.6% | €140.2m | €12.75 | PE28.5x | E22.8% | n/a | Capital Goods | ||
ELABS | kr13.80 | -14.3% | 26.1% | kr1.5b | kr25.00 | PS21.3x | E124.6% | n/a | Software | ||
FDE | €38.30 | 3.0% | -8.2% | €200.3m | €64.07 | PE25.5x | E37.7% | n/a | Energy | ||
OSE | €8.01 | -3.8% | 119.2% | €173.8m | €7.15 | PS78.1x | E92.9% | n/a | Pharmaceuticals & Biotech | ||
DIRR3 | R$25.20 | 0.08% | 41.3% | R$4.3b | R$29.73 | PE10.3x | E20.4% | 1.9% | Consumer Durables | ||
PLT | AU$0.71 | -5.3% | 73.2% | AU$127.5m | AU$1.30 | PB4.7x | E106.4% | n/a | Diversified Financials | ||
EH | US$16.54 | 2.0% | 65.2% | US$1.0b | US$26.84 | PS48.3x | E101.9% | n/a | Capital Goods | ||
NVDA | US$1,148.25 | 20.9% | 203.5% | US$2.8t | US$1,171.21 | PE66.3x | E22.7% | 0.01% | Semiconductors |